Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.

Proceedings of the National Academy of Sciences of the United States of America
R D HorstmannV A Fischetti

Abstract

Isolated complement components were used to study the regulation of the alternative complement pathway C3 convertase (EC 3.4.21.47), also called C3b,Bb, on M protein-carrying (M+) and M protein-lacking (M-) streptococci. Neither M- nor M+ streptococci directly affected the formation or dissociation of the surface-bound C3b,Bb or the inactivation of surface-bound C3b by factor I. However, the activity of the serum control protein of the alternative complement pathway, factor H, in controlling streptococcus-bound C3b and C3b,Bb was 6-8 times stronger on M+ organisms than on M- organisms. Furthermore, M+ streptococci of different serotypes and purified streptococcal M6 protein were shown to selectively bind factor H, the dissociation constants ranging from 4.5 X 10(-6) M to 6 X 10(-7) M. We conclude that the antiphagocytic activity of streptococcal M protein may be due to complement inhibition mediated by the binding of factor H. Binding of a regulatory protein appears to be a previously unrecognized route by which a pathogen is able to evade alternative pathway activation.

References

Nov 2, 1976·The Journal of Experimental Medicine·K Whaley, S Ruddy
Apr 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·D T Fearon, K F Austen
Jul 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·S K Law, R P Levine
Apr 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D T Fearon
May 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·M K Pangburn, H J Müller-Eberhard
Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D T Fearon
May 1, 1979·The Journal of Infectious Diseases·P K PetersonP G Quie
Sep 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·J M WeilerD T Fearon
Sep 1, 1986·European Journal of Immunology·R D Horstmann, H J Müller-Eberhard
Mar 1, 1985·The Journal of Experimental Medicine·K F JonesV A Fischetti
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J R ScottV A Fischetti
Apr 1, 1972·The Journal of Experimental Medicine·H J Müller-Eberhard, O Götze
Jan 1, 1974·The Journal of Experimental Medicine·O Götze, H J Müller-Eberhard
Aug 19, 1983·Science·J R Scott, V A Fischetti
Aug 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G N PhillipsV A Fischetti
Aug 1, 1959·The Journal of Experimental Medicine·R C LANCEFIELD

❮ Previous
Next ❯

Citations

May 1, 1995·Medical Microbiology and Immunology·B FleischerK H Schmidt
Jan 1, 1994·Springer Seminars in Immunopathology·M C Moffitt, M M Frank
Jan 1, 1994·Springer Seminars in Immunopathology·Z Fishelson
May 31, 2008·Current Infectious Disease Reports·Karen L Kotloff
Jan 19, 2008·Journal of Biosciences·B R Mohanty, P K Sahoo
Jul 1, 1989·Molecular and Biochemical Parasitology·C WernerT V Rajan
Nov 1, 1993·Veterinary Microbiology·J F Timoney, M M Mukhtar
Jul 1, 1993·Veterinary Microbiology·N ChanterT J Alexander
Feb 1, 1996·Research in Immunology·J P Atkinson
Feb 1, 1989·Current Opinion in Immunology·S H Kaufmann
Aug 14, 2003·Molecular Immunology·Hanna JarvaSeppo Meri
Jul 14, 1999·Molecular Immunology·P F ZipfelS Meri
Jul 17, 1999·Immunopharmacology·P F ZipfelS Meri
Feb 1, 1992·Current Opinion in Immunology·M M Frank
Feb 19, 2000·Current Opinion in Immunology·G LindahlE Johnsson
Jul 26, 2003·Protein Expression and Purification·Peter OsmarkBo Akerström
Dec 28, 1999·Microbes and Infection·C Mold
May 18, 2000·Microbes and Infection·R Rautemaa, S Meri
Mar 5, 2003·Current Opinion in Microbiology·Ulrich von Pawel-Rammingen, Lars Björck
Apr 8, 2003·The Lancet Infectious Diseases·A L BisnoC M Collins
May 23, 2001·International Immunopharmacology·E GiannakisD L Gordon
May 23, 2001·International Immunopharmacology·P KraiczyV Brade
Feb 10, 2007·Epidemiology and Infection·T IkebeUNKNOWN Working Group for Beta-haemolytic Streptococci in Japan
Dec 17, 2009·Cell Research·Jason R Dunkelberger, Wen-Chao Song
May 15, 2010·Nature Reviews. Microbiology·Davide SerrutoJos A G van Strijp
Mar 24, 2004·Nature Reviews. Microbiology·Timothy J Mitchell
Apr 5, 2001·The New England Journal of Medicine·M J Walport
Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M W CunninghamC J Gauntt
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·N OkadaM Caparon
Oct 1, 2003·The Journal of Experimental Medicine·Fredric CarlssonGunnar Lindahl
Dec 12, 2012·The Journal of Experimental Medicine·Pontus NordenfeltLars Björck
Jun 12, 2008·The Journal of Infectious Diseases·Pamela S HairKenji M Cunnion

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.